Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Theravance Biopharma revenue increased from $15.4 million in 2017 to $60.4 million in 2018, a (292.4%) increase.

Annual Revenue ($)

Theravance Biopharma revenue was $60.37 m in FY, 2018 which is a (292.4%) year over year increase from the previous period.

Quarterly Revenue ($)

FY, 2016FY, 2017FY, 2018
Revenue$48.65 m$15.39 m$60.37 m
Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018
Revenue$18.41 m$5.47 m$19.08 m$3.09 m$3.51 m$4.28 m$8.32 m$23.48 m$12.84 m

Annual Growth Rate (%)

Revenue Breakdown

Geographic Segment

Theravance Biopharma revenue breakdown by geographic segment: 18.4% from Europe, 81.6% from US and 0.0% from Other

FY, 2017FY, 2016FY, 2018
Europe$1.11 m$15.21 m$11.12 m
Asia$5 k$4 k$14 k
US$14.27 m$33.18 m$49.24 m

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu